Xeloda
NDC 54868-5260
Product Information
Xeloda is a NDA-approved product labeled by Physicians Total Care, Inc.. Capecitabine is used to treat breast, colon, or rectal cancer. It is supplied as a pink product. This product entry covers the primary NDC 54868-5260 and 6 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
XELODA;150
XELODA;500
Code Structure Chart
Product Details
What is NDC 54868-5260?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- CAPECITABINE (UNII: 6804DJ8Z9U)
- CAPECITABINE (UNII: 6804DJ8Z9U) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- HYPROMELLOSE 2208 (15000 MPA.S) (UNII: Z78RG6M2N2)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- WATER (UNII: 059QF0KO0R)
- TALC (UNII: 7SEV7J4R1U)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- FERRIC OXIDE RED (UNII: 1K09F3G675)
- FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 200327 - capecitabine 150 MG Oral Tablet
- RxCUI: 200328 - capecitabine 500 MG Oral Tablet
- RxCUI: 213292 - Xeloda 150 MG Oral Tablet
- RxCUI: 213292 - capecitabine 150 MG Oral Tablet [Xeloda]
- RxCUI: 213293 - Xeloda 500 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.